{"id":168194,"date":"2024-01-04T02:38:02","date_gmt":"2024-01-04T07:38:02","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/lyell-immunopharma-to-participate-in-42nd-annual-j-p-morgan-healthcare-conference\/"},"modified":"2024-08-18T11:47:14","modified_gmt":"2024-08-18T15:47:14","slug":"lyell-immunopharma-to-participate-in-42nd-annual-j-p-morgan-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/lyell-immunopharma-to-participate-in-42nd-annual-j-p-morgan-healthcare-conference.php","title":{"rendered":"Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference"},"content":{"rendered":"<p><![CDATA[SOUTH SAN FRANCISCO, Calif., Jan.  03, 2024  (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical?stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, announced today that members of its senior management team will present and participate in the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10 at 8:15 am Pacific Time.]]><\/p>\n<p>Read the original here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/01\/03\/2803611\/0\/en\/Lyell-Immunopharma-to-Participate-in-42nd-Annual-J-P-Morgan-Healthcare-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference\">Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original here: Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/lyell-immunopharma-to-participate-in-42nd-annual-j-p-morgan-healthcare-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-168194","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168194"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=168194"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168194\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=168194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=168194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=168194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}